Faculty profile

Heather Reich

ResearcherMedicine/NephrologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Heather Reich

Researcher

Medicine/Nephrology

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2026.
Principal investigator on 6 research grants (6 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

171

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Iga Nephropathy Glomerulonephritis B Cells Cytokine Immunology Kidney Disease Biomarkers Chronic Kidney Disease

Latest papers

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines
Canadian Journal of Kidney Health and Disease · 2026
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
Nature genetics · 2023
Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease.
International journal of molecular sciences · 2021

All 24 publications

Latest funding

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot
CIHR · 2023 · Co-investigator
$520,200
Looking, Listening, Learning, Leading: Canadians Seeking Solutions and Innovations to Overcome; Chronic Kidney Disease (Can-SOLVE CKD)
CIHR · 2021 · Principal investigator
$3,750,000
Rethinking the role of B cells in IgA nephropathy
CIHR · 2020 · Nominated PI
$596,700

All 9 grants and awards

24 publications.

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines

Jauhal A, Mustafa R, Mathew A, Girard L, Barbour S, Prasad B, Bathini L, Poyah P, Troyanov S, Samanta R

Canadian Journal of Kidney Health and Disease20261 citations

DOI: 10.1177/20543581251409874

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, Khan A, Marasa M, Zhang JY, Balderes O, Sanna-Cherchi S, Bomback AS, Canetta PA, Appel GB, Radhakrishnan J, Trimarchi H, Sprangers B, Cattran DC, Reich H, Pei Y, Ravani P, Galesic K, Maixnerova D, Tesar V, Stengel B, Metzger M, Canaud G, Maillard N, Berthoux F, Berthelot L, Pillebout E, Monteiro R, Nelson R, Wyatt RJ, Smoyer W, Mahan J, Samhar AA, Hidalgo G, Quiroga A, Weng P, Sreedharan R, Selewski D, Davis K, Kallash M, Vasylyeva TL, Rheault M, Chishti A, Ranch D, Wenderfer SE, Samsonov D, Claes DJ, Akchurin O, Goumenos D, Stangou M, Nagy J, Kovacs T, Fiaccadori E, Amoroso A, Barlassina C, Cusi D, Del Vecchio L, Battaglia GG, Bodria M, Boer E, Bono L, Boscutti G, Caridi G, Lugani F, Ghiggeri G, Coppo R, Peruzzi L, Esposito V, Esposito C, Feriozzi S, Polci R, Frasca G, Galliani M, Garozzo M, Mitrotti A, Gesualdo L, Granata S, Zaza G, Londrino F, Magistroni R, Pisani I, Magnano A, Marcantoni C, Messa P, Mignani R, Pani A, Ponticelli C, Roccatello D, Salvadori M, Salvi E, Santoro D, Gembillo G, Savoldi S, Spotti D, Zamboli P, Izzi C, Alberici F, Delbarba E, Florczak M, Krata N, Mucha K, Pączek L, Niemczyk S, Moszczuk B, Pańczyk-Tomaszewska M, Mizerska-Wasiak M, Perkowska-Ptasińska A, Bączkowska T, Durlik M, Pawlaczyk K, Sikora P, Zaniew M, Kaminska D, Krajewska M, Kuzmiuk-Glembin I, Heleniak Z, Bullo-Piontecka B, Liberek T, Dębska-Slizien A, Hryszko T, Materna-Kiryluk A, Miklaszewska M, Szczepańska M, Dyga K, Machura E, Siniewicz-Luzeńczyk K, Pawlak-Bratkowska M, Tkaczyk M, Runowski D, Kwella N, Drożdż D, Habura I, Kronenberg F, Prikhodina L, van Heel D, Fontaine B, Cotsapas C, Wijmenga C, Franke A, Annese V, Gregersen PK, Parameswaran S, Weirauch M, Kottyan L, Harley JB, Suzuki H, Narita I, Goto S, Lee H, Kim DK, Kim YS, Park JH, Cho B, Choi M, Van Wijk A, Huerta A, Ars E, Ballarin J, Lundberg S, Vogt B, Mani LY, Caliskan Y, Barratt J, Abeygunaratne T, Kalra PA, Gale DP, Panzer U, Rauen T, Floege J, Schlosser P, Ekici AB, Eckardt KU, Chen N, Xie J, Lifton RP, Loos RJF, Kenny EE, Ionita-Laza I, Köttgen A, Julian BA, Novak J, Scolari F, Zhang H, Gharavi AG

Nature genetics2023

DOI: 10.1038/s41588-023-01422-x PMID: 37337107

Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease.

Maksimowski NA, Song X, Bae EH, Reich H, John R, Pei Y, Scholey JW, Nephrotic Syndrome Study Network Neptune

International journal of molecular sciences2021

DOI: 10.3390/ijms22179513 PMID: 34502419

Type IV Collagen Variants in CKD: Performance of Computational Predictions for Identifying Pathogenic Variants.

Shulman C, Liang E, Kamura M, Udwan K, Yao T, Cattran D, Reich H, Hladunewich M, Pei Y, Savige J, Paterson AD, Suico MA, Kai H, Barua M

Kidney medicine2021

DOI: 10.1016/j.xkme.2020.12.007 PMID: 33851121

Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function

Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH-L, Chong K, Dart A, Ferera J, Fernandez N

Canadian Journal of Kidney Health and Disease201874 citations

DOI: 10.1177/2054358117749530

An update on predicting renal progression in IgA nephropathy.

Barbour S, Reich H

Current opinion in nephrology and hypertension2018Senior author

DOI: 10.1097/mnh.0000000000000405 PMID: 29432215

Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes.

Sochett E, Noone D, Grattan M, Slorach C, Moineddin R, Elia Y, Mahmud FH, Dunger DB, Dalton N, Cherney D, Scholey J, Reich H, Deanfield J

Cytokine2017

DOI: 10.1016/j.cyto.2017.07.013 PMID: 28760408

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V, TESTING Study Group

JAMA2017

DOI: 10.1001/jama.2017.9362 PMID: 28763548

Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Cattran DC, Kim ED, Reich H, Hladunewich M, Kim SJ, Toronto Glomerulonephritis Registry group

Journal of the American Society of Nephrology : JASN2017

DOI: 10.1681/asn.2015111262 PMID: 27756808

A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.

Landolt-Marticorena C, Prokopec SD, Morrison S, Noamani B, Bonilla D, Reich H, Scholey J, Avila-Casado C, Fortin PR, Boutros PC, Wither J

Arthritis research & therapy2016

DOI: 10.1186/s13075-016-1120-0 PMID: 27716443

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot

Co-investigatorCIHR2023Project Grant

Principal investigators: Walsh, Michael W; Massicotte-Azarniouch, David; Mendel, Arielle

Keywords: Anca; Autoimmune Disease; Dialysis; Kidney Failure; Kidney Function; Vasculitis

$520,200

Looking, Listening, Learning, Leading: Canadians Seeking Solutions and Innovations to Overcome; Chronic Kidney Disease (Can-SOLVE CKD)

Principal investigatorCIHR2021SPOR Networks - Knowledge Mobilization and Implementation Science

Principal investigators: Levin, Adeera; Beaucage, Mary B; Desjarlais, Arlene D; Hillier, David R; McCormick, Michael; Morrin, Louise; Stalker, Leanne; Verdin, Nancy E; Voyageur, Evelyn; Wilson, Mary; Woods, Cathy; Ahmed, Sofia B; Barrett, Brendan J; Battistella, Marisa; Bello, Aminu; Bohm, Clara; Collister, David; Dart, Allison B; Donald, Maoliosa (Mo); Elliott, Meghan; Garg, Amit; Hartwig, Sunny; James, Matthew T; King, Malcolm; Louie, Kelsey; Manns, Braden J; Matsuda-Abedini, Mina; McIntyre, Christopher W; Reich, Heather; Rigatto, Claudio; Sapir-Pichhadze, Ruth; Schick-Makaroff, Kara L; Scholey, James W; Silver, Samuel; Tangri, Navdeep; Tennankore, Karthik K; Thompson, Stephanie; Wicklow, Brandy A; Zappitelli, Michael

Keywords: Cardiovascular Disease; Chronic Kidney Disease; Community Driven; Diabetes; Health Services Research; Implementation; Indigenous Health Research; Knowledge Mobilization; Patient-Oriented Research; Storytelling

$3,750,000

Rethinking the role of B cells in IgA nephropathy

Nominated PICIHR2020Project Grant

Principal investigators: Reich, Heather

Keywords: B Cells; Cytokine; Glomerulonephritis; Iga Nephropathy; Immunology; Kidney Disease

$596,700

Development of a personalized medicine approach to corticosteroid treatment in IgA nephropathy

Principal investigatorCIHR2019Project Grant

Principal investigators: Barbour, Sean; Cattran, Daniel C; Reich, Heather; Shechter, Steven

Keywords: Corticosteroid Treatment; Decision Analysis; Iga Nephropathy; Personalized Medicine; Precision Medicine; Prediction Model

$292,976

Personalized Treatment in IgA Nephropathy - the PersTIgAN study

Nominated PICIHR2018Team Grant: ERA-Net PerMed

Principal investigators: Reich, Heather

Keywords: Biomarkers; Chronic Kidney Disease; Glomerulonephritis; Iga Nephropathy; Personalised Medicine; Prediction; Proteomics

$285,051

The derivation, validation and implementation of an international risk prediction tool in IgA nephropathy

Principal investigatorCIHR2017Catalyst Grant: Personalized Health Catalyst Grants

Principal investigators: Barbour, Sean; Cattran, Daniel C; Gagliardi, Anna R; Kim, Sang J; Reich, Heather

Keywords: Chronic Kidney Disease; End-Stage Renal Disease; Glomerulonephritis; Iga Nephropathy; Risk Prediction Model; Risk Prediction Tool

$199,930

The impact of TNF family cytokines on host-microbiome interactions in the context of a chronic kidney disease

Co-investigatorCIHR2016Project Grant

Principal investigators: Gommerman, Jennifer L

Keywords: Iga; Kidney Disease; Microbiome

$745,389

The Therapeutic Evaluation of STeroids in IgA Nephropathy Global (TESTING) Study - Canadian Network

Principal investigatorCIHR2012Operating Grant

Principal investigators: Hladunewich, Michelle A; Cattran, Daniel C; Levin, Adeera; Reich, Heather

Keywords: Iga Nephropathy; Methylprednisolone; Randomized Placebo Controlled Trial

$884,666

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomized controlled trial

Co-investigatorCIHR2009Operating Grant

Principal investigators: Clark, William F

Keywords: Glucocorticoid; Plasma Exchange; Plasmapheresis; Randomized Control Trial; Vasculitis; Wegener'S Granulomatosis

$403,518

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Heather Reich

Research

Latest papers

Latest funding

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease.

Type IV Collagen Variants in CKD: Performance of Computational Predictions for Identifying Pathogenic Variants.

Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function

An update on predicting renal progression in IgA nephropathy.

Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes.

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Membranous Nephropathy: Quantifying Remission Duration on Outcome.

A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.

Frequent collaborators

James Scholey

Michelle Hladunewich

Michael Walsh

Joan Wither

York Pei

Wendy Lou

Allison Dart

Sean Barbour

Daniel Cattran

Murray Urowitz

Dafna Gladman

Adeera Levin

Etienne Sochett

Navdeep Tangri

Ana Konvalinka

Nataliya Milman

Rahim Moineddin

Cathy Woods

Jeffrey Johnson

Susan Samuel

Marinka Twilt

Paul Komenda

Michael McCormick

Ayodele Odutayo

Brenda Hemmelgarn

Leilani Famorca

Bernard Zinman

Gerard Cox

Braden Manns

Nader Khalidi

Amit Garg

Reem Adel Mustafa